Cancer is a leading cause of death in dogs, and while certain breeds are predisposed to specific types of cancer, mixed-breed dogs are not exempt from the risk. Assessing the cancer risk in your mixed-breed dog requires an understanding of genetic predispositions, environmental factors, and lifestyle choices. While you can’t change genetics, there are steps you can take to mitigate risk and catch potential signs early.
Mixed-breed dogs are often considered to be more genetically diverse and may have fewer inherited health problems compared to purebred dogs. However, that doesn’t mean they are immune to cancer. Certain cancers, such as hemangiosarcoma, osteosarcoma, and lymphoma, can occur in dogs of all breeds, including mixed breeds.
The key lies in the combination of genes passed down from the dog’s parents.
If your mixed-breed dog is a mix of breeds that are known to have higher rates of certain cancers, they may have an increased risk for those conditions.
Any mixed breed with golden retriever, Labrador retriever, or pit bull has increased risk of lymphoma according to ImpriMed’s database.
Environmental factors can play a significant role in the development of cancer. A dog’s surroundings, diet, and lifestyle can influence their overall health and cancer risk. Here are some considerations:
Early detection of cancer can significantly improve your dog’s prognosis. Being vigilant about your dog’s health and regularly examining them for changes is crucial. Common signs of cancer in dogs include:
If your dog is diagnosed with lymphoma, chemotherapy can be a successful treatment. The CHOP protocol is a commonly employed against lymphoma. It is an acronym for a chemotherapy regimen consisting of four drugs: Cyclophosphamide (Cytoxan), Hydroxydaunorubicin (Doxorubicin), Vincristine (Oncovin) and Prednisone or Prednisolone.
ImpriMed helps determine which anticancer drugs a dog will respond well to with a process that involves artificial intelligence and its vast experience with other dogs.
“Our Personalized Prediction Profile uses your dog’s live cancer cells to create a hyper-specific approach for your pet,” says Mary Ocnean, Vice President of Commercial Operations at ImpriMed. “The assay (or test) predicts how that patient will respond to some of the most commonly used treatment regimens, so your vet will have every tool in their arsenal available to give your dog the best life possible.”
While mixed-breed dogs may have a lower risk of inherited cancers compared to purebreds, they are still susceptible to developing cancer. Owners can help assess and mitigate cancer risks for their pets by being proactive about their lifestyle choices and monitoring for early signs of illness, and initiating the most effective treatment methods if there is a cancer diagnosis.
Regular vet visits and early detection are key in giving your dog the best chance for a long and healthy life.
References: